Latest

A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆

Markets · 15 min delay

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

ISEQ9,241.3▲ +0.62%

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

Irish Medicines Database · HPRA register

M-M-RvaxPro powder and solvent for suspension for injection Measles, mumps and rubella vaccine (live)

Authorisation EU/1/06/337/1-13 · Merck Sharp & Dohme BV,

← All medicines

M-M-RvaxPro powder and solvent for suspension for injection Measles, mumps and rubella vaccine (live)

Licence EU/1/06/337/1-13 · Unknown

Licence holder: Merck Sharp & Dohme BV, (all products →)
Active substances: Mumps virus live attenuated jeryl lynn strain, Rubella virus (wistar ra 27/3 strain) live attenuated, Measles virus live attenuated derived from the edmonston b strain
Dosage form: Powder and solvent for suspension for injection
Route of administration: Intramuscular use
ATC codes: J07BD, J07BD52
First authorised: 05/05/2006
Prescription status: Product subject to prescription which may not be renewed (A)
Supply: Supply through pharmacies only
Legal basis: Full application (Article 8(3) of Directive No 2001/83/EC)

Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.